belatacept sold brand name nulojix fusion protein composed fc fragment human immunoglobulin linked extracellular domain molecule crucial regulation cell costimulation selectively blocking process tcell activation intended provide extended graft survival limiting toxicity generated standard immune suppressing regimens calcineurin inhibitors differs abatacept orencia two amino acidsmedical citation needed belatacept developed bristolmyerssquibb approved us food drug administration fda june antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikibelatacept